There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Three sectors stand out for their exceptional potential: defense, energy, and pharmaceuticals. This momentum is represented in the pharmaceutical industry, where research laboratories still buy ...

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and ...

In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.

As part of the foreign aid freeze by President Donald Trump, the U.S. distribution of HIV drugs in poor countries has been ...